Expanding the findings of RV144 to South Africa: P5 initiative
virus vector and the DNA prime/ Ad5 boost vaccine regimen. However, in the RV144 study, modest efficacy was demonstrated by the ALVAC-HIV prime/AIDSVAX® B/E gp120 boost regimen ... months to augment durability. The HVTN…

